Abstract: A 30-year-old woman presented with a history of generalized tonic-clonic seizures since childhood, occurring for the first time at age 9. The initial diagnostic workup at age 13 demonstrated a distinctive calcified mass of the left frontal lobe on CT (figure, A). Together with a single facial nevus, the lesion was suspected to represent Sturge-Weber-like phakomatosis; however, the patient's clinical history and physical examination failed to reveal further evidence of a neurocutaneous syndrome. Neither MRI nor biopsy for histologic confirmation of the diagnosis was performed. At age 18 the patient was lost to follow-up at the children's hospital. 
Section 1
A 30 year old female patient presented with a history of generalized tonic-clonic seizures since childhood, occurring for the first time at the age of nine. The initial diagnostic work-up at age 13 demonstrated a distinctive calcified mass of the left frontal lobe on computerized tomography (CT) (Fig. 1A) . Together with a single facial nevus, the lesion was suspected to represent Sturge-Weber-like phakomatosis, however, the patient's clinical history and physical examination failed to reveal further evidence of a neurocutaneous syndrome.
Neither magnetic resonance imaging (MRI) nor biopsy for histological confirmation of the diagnosis was performed. At age 18, the patient was lost to follow-up at the Children's hospital.
At age 30, the patient, who had been on permanent antiepileptic treatment with valproic acid, suffered a generalized seizure prompting clinical and radiological re-assessment. The reported facial nevus was no longer detectable and the patient was free of neurological symptoms or signs. CT scan of the head revealed calcified masses of the left and right frontal lobes (Fig. 1B) , with considerable progression when compared to the initial CT scans obtained 17 years before.
-What is the differential diagnosis?
-What are suitable diagnostic measures?
Section 2
In the absence of significant clinical findings, the radiological differential diagnosis based on CT scans is broad including various primary and secondary brain tumors. Neoplasms with dense calcifications include, among others, oligodendroglioma, ganglioglioma and meningioma. Vascular pathologies including cavernous malformations or aneurysms and infectious lesions with calcifications such as tuberculosis must be considered. Furthermore, Sturge-Weber syndrome and other neurocutaneous disorders can be associated with cortical calcifications. More advanced imaging techniques may be helpful to allow for a more precise Tonder 4 diagnosis. An MRI scan confirmed the bifrontal masses with distinctive signal alterations on T1-and T2/FLAIR-weighted sequences of the surrounding brain parenchyma interpreted as chronic demyelinating and gliotic changes rather than acute vasogenic edema, consistent with the slow progression of the lesion. Contrast-enhanced T1 sequences demonstrated intense contrast enhancement in the non-calcified regions of the lesion (Fig 1C) . In order to assess the nature of the mass more precisely, 18 F-fluoro-ethyl-tyrosine positron emission tomography (18F-FET-PET) was performed, which displayed marked enhancement of tyrosine uptake compatible with metabolically active tissue (Fig. 1D ).
-What is the interpretation of the MRI and PET findings?
-How can the diagnosis be established?
Section 3
Overall, the imaging findings cannot be considered as typical of Sturge-Weber syndrome or any other neurocutaneous syndrome. However, the strong tyrosine uptake indicates metabolically active tissue and is suspicious for a malignant tumor. Based on these considerations, the decision was made to obtain a biopsy for histopathological assessment.
A microsurgical open biopsy was undertaken with neuronavigation guidance in a superficial isolated lesion including meningeal and cortical samples within high FET uptake and contrast-enhancement (Fig. 1E) . On gross examination, the tissue was noted to have a gritty texture and contained white flecks. Histological analysis revealed an unstructured, hypocellular mass with an amorphous vaguely chondroid to finely fibrillar core, somewhat resembling fibrocartilage, surrounded by mature lamellar bone and a superficial rind of spindle to epithelioid cells (Fig. 1F, upper panels) . Coarse cords of lumpy, slightly fibrillar matrix appeared to radiate towards the cortical layer of epithelial-like cells. These plump cortical cells with nuclear pseudoinclusions (Fig. 1F, lower left) were variably positive for epithelial membrane antigen (EMA) compatible with meningothelial origin (Fig. 1F, lower right). The MIB1 proliferation was low (<1%) and mostly restricted to the surface cells. Based Tonder 5 on the above features and the absence of other elements suggesting a neoplastic process, the diagnosis of "calcifying pseudoneoplasm of the neuraxis" was rendered.
Discussion
Calcifying pseudoneoplasms of the neuraxis (CAPNON) are rare lesions of the central nervous system (CNS) with only few patients reported to date [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . CAPNON can occur both intracranially and spinally without a predominant localization. It has been described in patients aging from 6 to 68 years with a preponderance of males [3] . The clinical symptoms and signs vary and depend on the localization of the mass with seizures as the most frequent symptom if the lesion is located intracranially [1, 2] . Of note, CAPNON is a descriptive diagnosis and the underlying pathological process is largely unknown. By definition, CAPNON is a discrete hypocellular, chondrocalcific, occasionally ossified mass that is covered by a surface layer of epithelioid cells of presumed meningothelial origin. According to the current interpretation, a reactive rather than a hamartomatous lesion has been assumed [2] . Other authors have suggested that the lesion represents abortive bone formation [7] or an extremely rare variant of a very low grade neoplasm [8] . CAPNONs present with distinctive imaging features as is illustrated in our case. CT scans typically show a densely calcified lesion [1] , whereas MRI mostly reveals hypointense T1 and T2 signals with mild and inhomogeneous internal or rim contrast enhancement [1, 4] .
The present case adds some novel aspects and is of particular interest because of the radiological documentation covering a period of 17 years which demonstrates that these lesions can grow over a very long period of time. Furthermore, this is the first report on the use of FET-PET in a CAPNON patient. The MRI demonstrated marked contrast enhancement in the non-calcified peripheral regions of the mass and a distinct T2/FLAIR signal alteration (Fig. 1C) , which differs from other reports. Furthermore, our patient underwent an 18 F-FET-PET scan, which displayed profoundly increased tyrosine uptake (Fig.   1D) ; however, FET-PET has not been previously reported in CAPNON patients. Of interest, 
